Cardio Flow’s FreedomFlow Orbital Atherectomy Platform Used in Initial Commercial Cases
November 7, 2023—Cardio Flow, Inc. recently announced the completion of the first commercial cases for the company’s FreedomFlow orbital atherectomy platform, which received FDA clearance in late September.